Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients

Cancer Letters

Volumn 311, Issue 1, 2011, Pages 29-37

  Son, Ji Woong ^a   Jeong, Kang Jin ^b   Jean, Woo Sean ^b   Park, Soon Young ^b   Jheon, Sanghoon ^c   Cho, Hyun Min ^a   Park, Chang Gyo ^b   Lee, Hoi Young ^b   Kang, Jaeku ^b  

^a Konyang University College of Medicine   (South Korea)

^b Konyang University   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

Copy number change; DNA methylation; Genetic and epigenetic relationship; HOXA9; Non small cell lung cancer

Indexed keywords

ADULT; AGED; ARTICLE; AUTOSOME; CHROMOSOME 1; CHROMOSOME 12Q; CHROMOSOME 12Q24.33; CHROMOSOME 13Q; CHROMOSOME 13Q34; CHROMOSOME 1P21.1; CHROMOSOME 1Q31.1; CHROMOSOME 2; CHROMOSOME 2Q33.3; CHROMOSOME 2Q37.3; CHROMOSOME 3; CHROMOSOME 3P12.3; CHROMOSOME 3Q26.1; CHROMOSOME 3Q26.31; CHROMOSOME 3Q29; CHROMOSOME 4; CHROMOSOME 4Q35.2; CHROMOSOME 7P; CHROMOSOME 7P15.2; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE; HOXA11 GENE; HOXA9 GENE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DNA COPY NUMBER VARIATIONS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 80052179100     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.06.021     Document Type: Article

References (43)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics. CA Cancer J. Clin. 2010, 60:277-300.
2. Spiro S.G., Silvestri G.A. One hundred years of lung cancer. Am. J. Respir. Crit. Care Med. 2005, 172:523-529.
3. Sriram K.B., Larsen J.E., Yang I.A., Bowman R.V., Fong K.M. Genomic medicine in non-small cell lung cancer: paving the path to personalized care. Respirology 2011, 16:257-263.
4. Anglim P.P., Alonzo T.A., Laird-Offringa I.A. DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update. Mol. Cancer 2008, 7:81.
5. Lin Q., Geng J., Ma K., Yu J., Sun J., Shen Z., Bao G., Chen Y., Zhang H., He Y., Luo X., Feng X., Zhu J. RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China. J. Cancer Res. Clin. Oncol. 2009, 135:1675-1684.
6. Ionita-Laza I., Rogers A.J., Lange C., Raby B.A., Lee C. Genetic association analysis of copy-number variation (CNV) in human disease pathogenesis. Genomics 2009, 93:22-26.
7. Gonzalez E., Kulkarni H., Bolivar H., Mangano A., Sanchez R., Catano G., Nibbs R.J., Freedman B.I., Quinones M.P., Bamshad M.J., Murthy K.K., Rovin B.H., Bradley W., Clark R.A., Anderson S.A., O'connell R.J., Agan B.K., Ahuja S.S., Bologna R., Sen L., Dolan M.J., Ahuja S.K. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005, 307:1434-1440.
8. Fanciulli M., Norsworthy P.J., Petretto E., Dong R., Harper L., Kamesh L., Heward J.M., Gough S.C., de Smith A., Blakemore A.I., Froguel P., Owen C.J., Pearce S.H., Teixeira L., Guillevin L., Graham D.S., Pusey C.D., Cook H.T., Vyse T.J., Aitman T.J. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat. Genet. 2007, 39:721-723.
9. Palmer C.N., Doney A.S., Lee S.P., Murrie I., Ismail T., Macgregor D.F., Mukhopadhyay S. Glutathione S-transferase M1 and P1 genotype, passive smoking, and peak expiratory flow in asthma. Pediatrics 2006, 118:710-716.
10. Sebat J., Lakshmi B., Malhotra D., Troge J., Lese-Martin C., Walsh T., Yamrom B., Yoon S., Krasnitz A., Kendall J., Leotta A., Pai D., Zhang R., Lee Y.H., Hicks J., Spence S.J., Lee A.T., Puura K., Lehtimäki T., Ledbetter D., Gregersen P.K., Bregman J., Sutcliffe J.S., Jobanputra V., Chung W., Warburton D., King M.C., Skuse D., Geschwind D.H., Gilliam T.C., Ye K., Wigler M. Strong association of de novo copy number mutations with autism. Science 2007, 316:445-449.
11. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., Stray S.M., Rippey C.F., Roccanova P., Makarov V., Lakshmi B., Findling R.L., Sikich L., Stromberg T., Merriman B., Gogtay N., Butler P., Eckstrand K., Noory L., Gochman P., Long R., Chen Z., Davis S., Baker C., Eichler E.E., Meltzer P.S., Nelson S.F., Singleton A.B., Lee M.K., Rapoport J.L., King M.C., Sebat J. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320:539-543.
12. Hirsch F.R., Varella-Garcia M., Cappuzzo F., McCoy J., Bemis L., Xavier A.C., Dziadziuszko R., Gumerlock P., Chansky K., West H., Gazdar A.F., Crino L., Gandara D.R., Franklin W.A., Bunn P.A. Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib. Ann. Oncol. 2007, 18:752-760.
13. Medina P.P., Castillo S.D., Blanco S., Sanz-Garcia M., Largo C., Alvarez S., Yokota J., Gonzalez-Neira A., Benitez J., Clevers H.C., Cigudosa J.C., Lazo P.A., Sanchez-Cespedes M. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer. Hum. Mol. Genet. 2009, 18:1343-1352.
14. Iwakawa R., Kohno T., Kato M., Shiraishi K., Tsuta K., Noguchi M., Ogawa S., Yokota J. MYC amplification as a prognostic marker of early-stage lung adenocarcinoma identified by whole genome copy number analysis. Clin. Cancer Res. 2011, 17:1481-1489.
15. Jones P.A., Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 2002, 3:415-428.
16. Toyooka S., Toyooka K.O., Maruyama R., Virmani A.K., Girard L., Miyajima K., Harada K., Ariyoshi Y., Takahashi T., Sugio K., Brambilla E., Gilcrease M., Minna J.D., Gazdar A.F. DNA methylation profiles of lung tumors. Mol. Cancer Ther. 2001, 1:61-67.
17. Pfeifer G.P., Rauch T.A. DNA methylation patterns in lung carcinomas. Semin. Cancer Biol. 2009, 19:181-187.
18. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002, 21:5400-5413.
19. Eden A., Gaudet F., Waghmare A., Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003, 300:455.
20. Suzuki K., Suzuki I., Leodolter A., Alonso S., Horiuchi S., Yamashita K., Perucho M. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 2006, 9:199-207.
21. Brena R.M., Morrison C., Liyanarachchi S., Jarjoura D., Davuluri R.V., Otterson G.A., Reisman D., Glaros S., Rush L.J., Plass C. Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer. PLOS Med. 2007, 4:572-584.
22. Schumacher A., Kapranov P., Kaminsky Z., Flanagan J., Assadzadeh A., Yau P., Virtanen C., Winegarden N., Cheng J., Gingeras T., Petronis A. Microarray-based DNA methylation profiling: technology and applications. Nucleic Acids Res. 2006, 34:528-542.
23. Bibikova M., Lin Z., Zhou L., Chudin E., Garcia E.W., Wu B., Doucet D., Thomas N.J., Wang Y., Vollmer E., Goldmann T., Seifart C., Jiang W., Barker D.L., Chee M.S., Floros J., Fan J.B., High-throughput D.N.A. High-throughput DNA methylation profiling using universal bead arrays. Genome Res. 2006, 16:383-393.
24. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Stat. Soc. B 1995, 57:289-300.
25. J.K. Myung, J.B. Jeong, D. Han, C.S. Song, H.J. Moon, Y.A. Kim, J.E. Kim, S.J. Byun, W.H. Kim, M.S. Chang, Well-differentiated liposarcoma of the oesophagus: clinicopathological, immunohistochemical and array CGH analysis, Pathol. Oncol. Res. doi: doi:10.1007/s12253-010-9322-2.
26. Karpinets T.V., Foy B.D. Tumorigenesis: the adaptation of mammalian cells to sustained stress environment by epigenetic alterations and succeeding matched mutations. Carcinogenesis 2005, 26:1323-1334.
27. Henschke C.I., Yankelevitz D.F., Libby D.M., Pasmantier M.W., Smith J.P., Miettinen O.S. Survival of patients with stage I lung cancer detected on CT screening. New Eng. J. Med. 2006, 355:1763-1771.
28. Markowitz S.B., Miller A., Miller J., Manowitz A., Kieding S., Sider L., Morabia A. Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules. Chest 2007, 131:1028-1034.
29. Risch A., Plass C. Lung cancer epigenetics and genetics. Int. J. Cancer 2008, 123:1-7.
30. Minna J.D., Roth J.A., Gazdar A.F. Focus on lung cancer. Cancer Cell 2002, 1:49-52.
31. Olejniczak E.T., Van Sant C., Anderson M.G., Wang G., Tahir S.K., Sauter G., Lesniewski R., Semizarov D. Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains. Mol. Cancer Res. 2007, 5:331-339.
32. Choi J.S., Zheng L.T., Ha E., Lim Y.J., Kim Y.H., Wang Y.P., Lim Y. Comparative genomic hybridization array analysis and real-time PCR reveals genomic copy number alteration for lung adenocarcinomas. Lung 2006, 184:355-362.
33. Park J.J., Kang J.K., Hong S., Ryu E.S., Kim J.I., Lee J.H., Seo J.S. Genome-wide combination profiling of copy number and methylation offers an approach for deciphering misregulation and development in cancer cells. Gene 2008, 407:139-147.
34. Schneider K.U., Dietrich D., Fleischhacker M., Leschber G., Merk J., Schäper F., Stapert H.R., Vossenaar E.R., Weickmann S., Liebenberg V., Kneip C., Seegebarth A., Erdogan F., Rappold G., Schmidt B. Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors. BMC Cancer 2011, 11:102.
35. Gehring W.J., Hiromi Y. Homeotic genes and the homeobox. Annu. Rev. Genet. 1986, 20:147-173.
36. Cillo C., Barba P., Freschi G., Bucciarelli G., Magli M.C., Boncinelli E. HOX gene expression in normal and neoplastic human kidney. Int. J. Cancer 1992, 51:892-897.
37. De Vita G., Barba P., Odartchenko N., Givel J.C., Freschi G., Bucciarelli G., Magli M.C., Boncinelli E., Cillo C. Expression of homeobox-containing genes in primary and metastatic colorectal cancer. Eur. J. Cancer 1993, 29:887-893.
38. Cantile M., Cindolo L., Napodano G., Altieri V., Cillo C. Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas. Oncogene 2003, 22:6462-6468.
39. Maeda K., Hamada J., Takahashi Y., Tada M., Yamamoto Y., Sugihara T., Moriuchi T. Altered expressions of HOX genes in human cutaneous malignant melanoma. Int. J. Cancer 2005, 114:436-441.
40. Waltregny D., Alami Y., Clausse N., De Leval J., Castronovo V. Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation. Prostate 2002, 50:162-169.
41. Rauch T., Wang Z., Zhang X., Zhong X., Wu X., Lau S.K., Kernstine K.H., Riggs A.D., Pfeifer G.P. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc. Natl. Acad. Sci. USA 2007, 104:5527-5532.
42. Hwang S.H., Kim K.U., Kim J.E., Kim H.H., Lee M.K., Lee C.H., Lee S.Y., Oh T., An S. Detection of HOXA9 gene methylation in tumor tissues and induced sputum samples from primary lung cancer patients. Clin. Chem. Lab. Med. 2011, 49:699-704.
43. Gilbert P.M., Mouw J.K., Unger M.A., Lakins J.N., Gbegnon M.K., Clemmer V.B., Benezra M., Licht J.D., Boudreau N.J., Tsai K.K., Welm A.L., Feldman M.D., Weber B.L., Weaver V.M. HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. J. Clin. Invest. 2010, 120:1535-1550.